Role of apolipoprotein E in the pathogenesis of Alzheimer's disease and molecular mechanisms

被引:0
|
作者
Song, Zhenhai [1 ]
Xu, Shuo [2 ]
Song, Bin [3 ]
Zhang, Qinghua [1 ]
机构
[1] Shandong Prov Hosp, Dept Neurol, Jinan 250021, Shandong, Peoples R China
[2] Shandong Prov Hosp, Dept Radiol, Jinan, Shandong, Peoples R China
[3] Shandong Prov Hosp, Dept Emergency, Jinan, Shandong, Peoples R China
关键词
Apolipoprotein E; neural cell D283; clonal formation; small interference RNA; AMYLOID-BETA-PEPTIDE; NEURONAL CELL-DEATH; APOPTOSIS; MICE; AGE; NEUROGENESIS; PROTECT; INJURY; DOMAIN; APOE4;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Alzheimer's disease (AD), as one severe neurodegenerative disorder, severely threatens public health under the current aging of population. Some studies have speculated the presence of apolipoprotein E (apoE) in the occurrence and progression of AD. This study thus investigated the role of apoE in AD pathogenesis and related molecular mechanisms. Neural tissue samples from both AD model rats and normal rats were collected for quantifying apoE expression levels using RT- PCR and Western blotting. Cultured neural cells D283 were then transfected to over- express apoE or to down- regulate apoE using RNA interference approach. MTT assay and flow cytometry were applied to describe the growth and apoptosis of D283 cells. Clonal formation assay was then used to measure the ability of cell proliferation. AD rats had elevated apoE protein and mRNA levels compared to normal animals. Anti- sense siRNA of apoE inhibited the growth of D283 cells and induce their apoptosis, accompanied with lower clonal formation ability. The over- expression of apoE, on the contrary, facilitated cell growth, inhibited apoptosis, and potentiated clonal formation. ApoE expression level is closely correlated with AD. The lowering of apoE level inhibits neural cell D283 growth and clonal formation while induces cell apoptosis. Over- expression of apoE can facilitate cell growth and proliferation while inhibit apoptosis.
引用
收藏
页码:4615 / 4621
页数:7
相关论文
共 50 条
  • [1] Apolipoprotein E and Alzheimer's disease:: molecular mechanisms and therapeutic opportunities
    Cedazo-Minguez, Angel
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (06) : 1227 - 1238
  • [2] The Role of Apolipoprotein E in Alzheimer's Disease
    Kim, Jungsu
    Basak, Jacob M.
    Holtzman, David M.
    [J]. NEURON, 2009, 63 (03) : 287 - 303
  • [3] Role of apolipoprotein E in Alzheimer's disease
    Zannis, VI
    Zanni, EE
    Makrides, SC
    Kardassis, D
    Aleshkov, S
    [J]. VASCULAR ENDOTHELIUM: PHARMACOLOGIC AND GENETIC MANIPULATIONS, 1998, 294 : 179 - 209
  • [4] Role of apolipoprotein E in the molecular pathomechanism of Alzheimer disease
    Michikawa, Makoto
    [J]. JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 34 (01): : 5 - 9
  • [5] Apolipoprotein E in Synaptic Plasticity and Alzheimer's Disease: Potential Cellular and Molecular Mechanisms
    Kim, Jaekwang
    Yoon, Hyejin
    Basak, Jacob
    Kim, Jungsu
    [J]. MOLECULES AND CELLS, 2014, 37 (11) : 767 - 776
  • [6] Novel molecular mechanisms in Alzheimer's disease: The potential role of DEK in disease pathogenesis
    Greene, Allie N. N.
    Solomon, Matia B. B.
    Vinnedge, Lisa M. Privette M.
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [7] The Role of Apolipoprotein E Isoforms in Alzheimer's Disease
    Roda, Alejandro R.
    Montoliu-Gaya, Laia
    Villegas, Sandra
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (02) : 459 - 471
  • [8] Apolipoprotein E and Alzheimer's disease: signal transduction mechanisms
    Strittmatter, WJ
    [J]. NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE, 2001, 67 : 101 - 109
  • [9] Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease
    Poirier, J
    [J]. TRENDS IN MOLECULAR MEDICINE, 2003, 9 (03) : 94 - 101
  • [10] The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease
    Shinohara, Mitsuru
    Sato, Naoyuki
    [J]. DIABETES MELLITUS: A RISK FACTOR FOR ALZHEIMER'S DISEASE, 2019, 1128 : 85 - 101